| Call 2017 subtopics:
The need for principally novel drugs for treatment of cardiovascular diseases, cancer and infectious diseases is evident since these diseases represent the top causes of mortality world-wide (excluding incidents).
The investigation of rational design and high-throughput screening of potential drug candidates (leads) offers many possibilities for a successful EU-Russia scientific cooperation.
The understanding of specific molecular mechanisms/pathways which underlie the particular disease initiation and progression, treatment resistance, etc. allows for an identification of relevant biomarkers and promising targets for drug development.
Research projects should focus on the validation of known biomarkers using state-of-the-art technologies, the development of relevant pre-clinical models, and biomarkers for patient stratification to improve the response to therapies.
The investigation of potential disease-specific target biomolecules in order to characterize new molecular diagnostic tools for early stage drug discovery will be encouraged.
[PDF - 1.89 MB]